THYROID EYE DISEASE
Clinical trials for THYROID EYE DISEASE explained in plain language.
Never miss a new study
Get alerted when new THYROID EYE DISEASE trials appear
Sign up with your email to follow new studies for THYROID EYE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Thyroid eye drug trial halted early – what we know
Disease control TerminatedThis study tested a drug called secukinumab in adults with active, moderate-to-severe thyroid eye disease, a rare autoimmune condition that causes eye bulging and inflammation. The trial was stopped early, so only limited data were collected. The goal was to see if the drug could…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Thyroid eye disease drug trial halted: no safety concerns, but not effective enough
Disease control TerminatedThis study tested a drug called efgartigimod for adults with moderate-to-severe thyroid eye disease, a condition that causes bulging eyes and vision problems. The trial was stopped early because early results showed it was unlikely to work well enough. The drug was found to be sa…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Thyroid eye disease drug trial halted early – no safety worries
Disease control TerminatedThis study tested a drug called efgartigimod for adults with moderate-to-severe thyroid eye disease. About 105 people were expected to join, but the trial was stopped early because early results showed the drug likely wouldn't work well enough. Importantly, there were no safety c…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Hope for thyroid eye disease: can batoclimab keep eyes stable?
Disease control TerminatedThis study was for people with thyroid eye disease who finished a previous batoclimab trial. It had two parts: one group was watched to see how long the eye improvement lasted without treatment, and another group got batoclimab again to see if it could help those who didn't respo…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE3 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New drug K9 tested for thyroid eye disease – early results show promise
Symptom relief TerminatedThis early study tested a new drug called K9 in a small group of people with thyroid eye disease (TED). The main goal was to check safety and how the drug works in the body. Participants took K9 twice a day for up to 24 weeks, and researchers tracked side effects and changes in d…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE1 • Sponsor: Peter Timoney • Aim: Symptom relief
Last updated May 17, 2026 06:50 UTC